Read about the groundbreaking research pioneered at Cedars-Sinai in the Cedars-Sinai Technology Transfer Report (2016) (PDF).
Technology Transfer at Cedars-Sinai
The mission of the Technology Transfer Office (TTO) is to promote the commercial development of Cedars-Sinai research into products and services that advance healthcare and improve patient wellbeing. The TTO actively seeks industry partners to develop these technologies and works to establish mutually beneficial long-term relationships. In addition to helping inventors identify and engage with appropriate business partners for technology commercialization, the TTO also facilitates the negotiation of confidentiality disclosure agreements, inter-institutional agreements and license agreements. Furthermore, the TTO provides continuous support for important legal and administrative functions.
Available Technologies for Licensing
The TTO is always interested in partnerships that can bring our technologies to market. Working with us provides an opportunity for industry leaders to expand their portfolios with meaningful innovations. The Technology Publisher has a large array of technologies listed across multiple categories that can be searched and licensed.
An international leader in biomedical research, Cedars-Sinai ranks among the nation’s top non-university hospitals for competitive research funding from the National Institutes of Health.
Brain tumor vaccines, small-molecule cancer drugs and better ways to tackle inflammatory bowel disease are just a few of the innovations currently in the Cedars-Sinai research pipeline. Learn more about our research in the following areas:
- Biomedical Sciences
- Diabetes and Obesity
- Digestive Diseases
- Genetics and Genomics
- Immunology and Infectious Diseases
- Regenerative Medicine
- Women's Health
The TTO is happy to speak with industry partners to learn more about their interests and identify licensing opportunities at Cedars-Sinai. Email email@example.com and a dedicated team member will be in touch.